ATE144143T1 - Künstlicher impfstoff gegen aids-virus - Google Patents
Künstlicher impfstoff gegen aids-virusInfo
- Publication number
- ATE144143T1 ATE144143T1 AT89908567T AT89908567T ATE144143T1 AT E144143 T1 ATE144143 T1 AT E144143T1 AT 89908567 T AT89908567 T AT 89908567T AT 89908567 T AT89908567 T AT 89908567T AT E144143 T1 ATE144143 T1 AT E144143T1
- Authority
- AT
- Austria
- Prior art keywords
- vaccine against
- aids virus
- against aids
- artificial
- artificial vaccine
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 101710091045 Envelope protein Proteins 0.000 abstract 1
- 101710188315 Protein X Proteins 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000016784 immunoglobulin production Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/22—Viral peptide or viral protein
- Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/222,684 US5030449A (en) | 1988-07-21 | 1988-07-21 | Synthetic vaccine against AIDS virus |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE144143T1 true ATE144143T1 (de) | 1996-11-15 |
Family
ID=22833252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89908567T ATE144143T1 (de) | 1988-07-21 | 1989-07-19 | Künstlicher impfstoff gegen aids-virus |
Country Status (9)
Country | Link |
---|---|
US (1) | US5030449A (de) |
EP (1) | EP0429477B1 (de) |
JP (1) | JP2676166B2 (de) |
AT (1) | ATE144143T1 (de) |
AU (1) | AU624628B2 (de) |
CA (1) | CA1339240C (de) |
DE (1) | DE68927348T2 (de) |
IL (1) | IL91007A (de) |
WO (1) | WO1990000901A1 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5939074A (en) * | 1986-12-30 | 1999-08-17 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US6210873B1 (en) | 1987-08-28 | 2001-04-03 | Board Of Regents, The University Of Texas System | Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
US5456924A (en) * | 1988-12-23 | 1995-10-10 | Immunotec Research Corporation Ltd. | Method of treatment of HIV-seropositive individuals with dietary whey proteins |
EP0362909A3 (de) * | 1988-08-26 | 1990-11-14 | Akzo N.V. | Synthetische Polypeptide, immunochemisch aktiv mit HIV-Antikörpern |
CA2035576A1 (en) * | 1990-02-07 | 1991-08-08 | Alexander R. Neurath | Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120 hiv-1 |
CA2069507A1 (en) * | 1990-09-25 | 1992-03-26 | John A. Habeshaw | Aids therapy and vaccine |
EP0579747A4 (en) * | 1991-03-22 | 1994-07-06 | Univ Pennsylvania | Method of modulating mammalian t-cell response |
US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
AU665023B2 (en) * | 1991-08-29 | 1995-12-14 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Multideterminant peptide antigens that stimulate helper T lymphocyte response to HIV in a range of human subjects |
CA2124691A1 (en) * | 1991-12-02 | 1993-06-10 | Jagannadha K. Sastry | Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
WO1993019775A1 (en) * | 1992-03-31 | 1993-10-14 | Medimmune, Inc. | Administration of liposomes containing peptides or proteins including ctl eptitopes of hiv proteins |
DE69326069T2 (de) * | 1992-07-20 | 2000-03-23 | Univ Durham | Zusammensetzungen die die hiv replikation inhibieren |
DE4228787A1 (de) * | 1992-08-29 | 1994-03-03 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate |
DE59309207D1 (de) * | 1992-10-06 | 1999-01-21 | Dade Behring Marburg Gmbh | Retrovirus aus der HIV-Gruppe und dessen Verwendung |
US5607914A (en) * | 1993-01-13 | 1997-03-04 | Pioneer Hi-Bred International, Inc. | Synthetic antimicrobial peptides |
US5869624A (en) * | 1993-03-26 | 1999-02-09 | Progenics Pharmaceuticals, Inc. | HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
US6749856B1 (en) * | 1997-09-11 | 2004-06-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Mucosal cytotoxic T lymphocyte responses |
CA2398816A1 (en) | 2000-02-04 | 2001-08-09 | Duke University | Human immunodeficiency virus vaccine |
WO2003008537A2 (en) * | 2001-04-06 | 2003-01-30 | Mannkind Corporation | Epitope sequences |
CN101146550B (zh) * | 2004-12-29 | 2013-04-17 | 曼康公司 | 免疫原性组合物用于制备引发和增强免疫应答的试剂盒的用途 |
EP2550362B1 (de) | 2010-03-25 | 2017-01-04 | Oregon Health&Science University | Cmv-glycoproteine und rekombinante vektoren |
MX2013010924A (es) * | 2011-03-23 | 2014-11-10 | Smart Biotech Ltd | Metodo y equipo para estimar incidencia de virus de inmunodeficiencia humana (vih). |
PT2691530T (pt) | 2011-06-10 | 2018-05-10 | Univ Oregon Health & Science | Glicoproteínas e vectores recombinantes cmv |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
WO2015200070A1 (en) | 2014-06-17 | 2015-12-30 | The Research Foundation For The State University Of New York | Ship inhibition to induce expression of granulocyte colony stimulating factor in a subject |
EP3069730A3 (de) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987002775A1 (en) * | 1985-10-24 | 1987-05-07 | Southwest Foundation For Biomedical Research | Synthetic peptides and use for diagnosis and vaccination for aids and arc |
JPH0762031B2 (ja) * | 1986-12-30 | 1995-07-05 | アメリカ合衆国 | エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド |
JP2569185B2 (ja) * | 1988-01-26 | 1997-01-08 | アメリカ合衆国 | 抗hiv応答を喚起する合成抗原 |
EP0330359A3 (de) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion |
-
1988
- 1988-07-21 US US07/222,684 patent/US5030449A/en not_active Expired - Lifetime
-
1989
- 1989-07-17 IL IL9100789A patent/IL91007A/en not_active IP Right Cessation
- 1989-07-19 EP EP89908567A patent/EP0429477B1/de not_active Expired - Lifetime
- 1989-07-19 AU AU39670/89A patent/AU624628B2/en not_active Ceased
- 1989-07-19 AT AT89908567T patent/ATE144143T1/de not_active IP Right Cessation
- 1989-07-19 WO PCT/US1989/003123 patent/WO1990000901A1/en active IP Right Grant
- 1989-07-19 DE DE68927348T patent/DE68927348T2/de not_active Expired - Fee Related
- 1989-07-19 JP JP1508125A patent/JP2676166B2/ja not_active Expired - Fee Related
- 1989-07-20 CA CA000606251A patent/CA1339240C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL91007A0 (en) | 1990-02-09 |
AU624628B2 (en) | 1992-06-18 |
DE68927348D1 (de) | 1996-11-21 |
AU3967089A (en) | 1990-02-19 |
EP0429477A1 (de) | 1991-06-05 |
EP0429477A4 (en) | 1991-11-13 |
JP2676166B2 (ja) | 1997-11-12 |
DE68927348T2 (de) | 1997-02-13 |
CA1339240C (en) | 1997-08-05 |
US5030449A (en) | 1991-07-09 |
EP0429477B1 (de) | 1996-10-16 |
WO1990000901A1 (en) | 1990-02-08 |
IL91007A (en) | 1995-08-31 |
JPH03504384A (ja) | 1991-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE144143T1 (de) | Künstlicher impfstoff gegen aids-virus | |
EA200801798A1 (ru) | Виросомоподобные везикулы, содержащие антигены, производные от gp41 | |
PE20040554A1 (es) | Vacunas que comprenden proteinas de fusion | |
DE69333397D1 (de) | Retro-, inverso-, und retro-inverso synthetische peptidanaloge | |
ATE295895T1 (de) | Genetischer impfstoff gegen den immunschwäche virus | |
GB2255093A (en) | Hiv-1 core protein fragments | |
ES2100240T3 (es) | Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen. | |
WO1989002277A3 (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
ATE135743T1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
ITRM920350A1 (it) | Epitopi immunologicamente omologhi di hla e proteine del virus hiv. | |
AU6683400A (en) | Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat | |
ES2143996T3 (es) | Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv. | |
ATE248601T1 (de) | Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4 | |
HUP0202770A2 (hu) | Humán papillómavírus oltóanyag | |
DK56389A (da) | Forhindring og behandling af retroviralt frembragte sygdomme | |
ATE134878T1 (de) | Impfstoffe gegen metazoen-parasiten | |
DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
DE69428984T2 (de) | Stimulierung der immunantwort durch virales protein | |
ES2080024B1 (es) | Vacuna subunitaria recombinante contra la enfermedad hemorragica virica de los conejos. | |
PT636030E (pt) | Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1 | |
HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
IT1233419B (it) | Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria | |
FR2792639B1 (fr) | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida | |
BR9711809A (pt) | Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo | |
SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |